The clinical results confirmed PRKAR1A expression in various cancer types, including lung adenocarcinoma, lung squamous cell carcinoma, liver hepatocellular carcinoma, and breast cancer (Figure 13). Here, PRKAR1A is linked to squamous cell lung carcinoma.